.
.
.
.register
china's plans to import indian drugs fail to enthuse indian pharmaceutical firms
.
.'indian ip and liabilities law barrier to pharma r&d investment'
.-
.
understanding cholesterol effects of adalimumab by new techniques was another goal of gelfand and mehta's study. .